MedPath

Chlorthalidone

Chlorthalidone Tablets, 25 mg and 50 mg

Approved
Approval ID

bcd2b6f8-533a-4f50-b3e6-80427e6c19ac

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 19, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Chlorthalidone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72162-2133
Application NumberANDA212878
Product Classification
M
Marketing Category
C73584
G
Generic Name
Chlorthalidone
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 20, 2023
FDA Product Classification

INGREDIENTS (8)

CHLORTHALIDONEActive
Quantity: 25 mg in 1 1
Code: Q0MQD1073Q
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MICROCRYSTALLINE CELLULOSE 101Inactive
Code: 7T9FYH5QMK
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE AInactive
Code: H8AV0SQX4D
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Chlorthalidone - FDA Drug Approval Details